Relationship between MTHFR gene polymorphism and susceptibility to bronchial asthma and glucocorticoid efficacy in children
LI Min, TANG Yu, ZHAO Er-Yao, CHEN Chao-Hui, DONG Li-Li
Department of Respiratory Medicine, Children's Hospital Affiliated to Zhengzhou University/Henan Children's Hospital/Zhengzhou Children's Hospital, Zhengzhou 450018, China
Abstract Objective To study the association of methylenetetrahydrofolate reductase (MTHFR) gene polymorphism with susceptibility to bronchial asthma and glucocorticoid (GC) efficacy in children. Methods A total of 173 children with bronchial asthma who were hospitalized between June 2018 and December 2020 were selected as the observation group. The children received aerosol inhalation of GC for three consecutive months. A total of 178 healthy children who underwent physical examination during the same period were selected as the control group. PCR was used to detect the genotypes of the MTHFR C677T for the two groups. The differences in genotype distribution between the two groups were analyzed. Children with different genotypes in the observation group were compared in terms of immunoglobulin E (IgE), interleukin-8 (IL-8), leukotriene B4 (LTB4), lung function, and clinical outcome before and after treatment. Results TT genotype and T allele were significantly more frequent in the observation group than in the control group (P<0.001). TT/CT genotypes and T allele were independent risk factors for bronchial asthma (OR=6.615 and 7.055 respectively; P<0.001). After GC treatment, the children with CC, CT or TT genotypes experienced significantly decreased levels of IgE, IL-8, and LTB4 and significantly increased forced expiratory volume in 1 second (FEV1), forced vital capacity (FVC), and FEV1/FVC ratio (P<0.001). The children with TT genotype showed significantly lower levels of IL-8 and LTB4 than those with CC genotype, a significantly lower level of LTB4 than those with CT genotype, significantly higher FVC than those with CT genotype, and a significantly higher FEV1/FVC ratio than those with CC genotype (P<0.05). The children with TT genotype had better GC efficacy compared with those with CC genotype (P<0.05). TT genotype was an independent factor for good GC efficacy (OR=2.111, P=0.018). Conclusions MTHFR gene polymorphism is associated with asthma susceptibility and GC efficacy in children. Children carrying TT/CT genotypes have a higher risk of developing asthma, and those with TT genotype are more sensitive to GC treatment.
Corresponding Authors:
Tang Y, Email: httang0@163.com
E-mail: httang0@163.com
Cite this article:
LI Min,TANG Yu,ZHAO Er-Yao et al. Relationship between MTHFR gene polymorphism and susceptibility to bronchial asthma and glucocorticoid efficacy in children[J]. CJCP, 2021, 23(8): 802-808.
LI Min,TANG Yu,ZHAO Er-Yao et al. Relationship between MTHFR gene polymorphism and susceptibility to bronchial asthma and glucocorticoid efficacy in children[J]. CJCP, 2021, 23(8): 802-808.
Sun CG, Yue WJ, Yan XL, et al. Correlation of SOCS3 gene polymorphism with childhood asthma[J]. Eur Rev Med Pharmacol Sci, 2019, 23(17): 7563-7567. DOI: 10.26355/eurrev_201909_18876. PMID: 31539147.
Kogan V, Millstein J, London SJ, et al. Genetic-epigenetic interactions in asthma revealed by a genome-wide gene-centric search[J]. Hum Hered, 2018, 83(3): 130-152. DOI: 10.1159/000489765. PMID: 30669148. PMCID: PMC7365350.
Alghobashy AA, Elsharawy SA, Alkholy UM, et al. B2 adrenergic receptor gene polymorphism effect on childhood asthma severity and response to treatment[J]. Pediatr Res, 2018, 83(3): 597-605. DOI: 10.1038/pr.2017.304. PMID: 29658513.
Cao JH, Tian LJ, Li ZG, et al. Interleukin-7 gene polymorphism rs766736182 associates with the risk of asthma in children[J]. J Clin Lab Anal, 2019, 33(2): e22675. DOI: 10.1002/jcla.22675. PMID: 30239047. PMCID: PMC6818573.
Imani D, Eslami MM, Anani-Sarab G, et al. Interleukin-4 gene polymorphism (C33T) and the risk of the asthma: a meta-analysis based on 24 publications[J]. BMC Med Genet, 2020, 21(1): 232. DOI: 10.1186/s12881-020-01169-w. PMID: 33228581. PMCID: PMC7686752.
Wan L, Li YH, Zhang ZR, et al. Methylenetetrahydrofolate reductase and psychiatric diseases[J]. Transl Psychiatry, 2018, 8(1): 242. DOI: 10.1038/s41398-018-0276-6. PMID: 30397195. PMCID: PMC6218441.
Sookaromdee P, Wiwanitkit V. MTHFR C677T polymorphism and hypertension[J]. J Clin Hypertens (Greenwich), 2020, 22(2): 308. DOI: 10.1111/jch.13811. PMID: 31955498.
Liew SC, Gupta ED. Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism: epidemiology, metabolism and the associated diseases[J]. Eur J Med Genet, 2015, 58(1): 1-10. DOI: 10.1016/j.ejmg.2014.10.004. PMID: 25449138.
Zeng H, He DM, Zhao YH, et al. Association between MTHFR polymorphisms (MTHFR C677T, MTHFR A1298C) and recurrent implantation failure: a systematic review and meta-analysis[J]. Arch Gynecol Obstet, 2021, 303(4): 1089-1098. DOI: 10.1007/s00404-020-05851-5. PMID: 33128585.
Han IB, Kim OJ, Ahn JY, et al. Association of methylenetetrahydrofolate reductase (MTHFR 677C>T and 1298A>C) polymorphisms and haplotypes with silent brain infarction and homocysteine levels in a Korean population[J]. Yonsei Med J, 2010, 51(2): 253-260. DOI: 10.3349/ymj.2010.51.2.253. PMID: 20191019. PMCID: PMC2824873.
Ventura P, Venturelli G, Marcacci M, et al. Hyperhomocysteinemia and MTHFR C677T polymorphism in patients with portal vein thrombosis complicating liver cirrhosis[J]. Thromb Res, 2016, 141: 189-195. DOI: 10.1016/j.thromres.2016.03.024. PMID: 27065203.
Mohamed NA, Abdel-Rehim AS. Influence of vitamin D receptor gene FokI and ApaI polymorphisms on glucocorticoid response in patients with asthma[J]. Int Forum Allergy Rhinol, 2020, 10(4): 556-563. DOI: 10.1002/alr.22511. PMID: 31863554.
Zein J, Gaston B, Bazeley P, et al. HSD3B1 genotype identifies glucocorticoid responsiveness in severe asthma[J]. Proc Natl Acad Sci U S A, 2020, 117(4): 2187-2193. DOI: 10.1073/pnas.1918819117. PMID: 31932420. PMCID: PMC6995013.
Shiobara T, Chibana K, Watanabe T, et al. Dipeptidyl peptidase-4 is highly expressed in bronchial epithelial cells of untreated asthma and it increases cell proliferation along with fibronectin production in airway constitutive cells[J]. Respir Res, 2016, 17: 28. DOI: 10.1186/s12931-016-0342-7. PMID: 26975422. PMCID: PMC4791890.
Ma K, Lu N, Zou F, et al. Sirtuins as novel targets in the pathogenesis of airway inflammation in bronchial asthma[J]. Eur J Pharmacol, 2019, 865: 172670. DOI: 10.1016/j.ejphar.2019.172670. PMID: 31542484.
de Benedictis FM, Attanasi M. Asthma in childhood[J]. Eur Respir Rev, 2016, 25(139): 41-47. DOI: 10.1183/16000617.0082-2015. PMID: 26929420.